In patients with oropharyngeal squamous cell carcinoma undergoing radiotherapy, the presence of the rs1800470 variant of TGFβ1 may reduce and modify the risk of death and recurrence [59]. Here, TGFB1 is linked to oropharynx squamous cell carcinoma.